October 30, 2019
Q-linea positive FDA feedback for planned trial with ASTar in USA
Q-linea AB has received the official response including a number of clarifications and very positive feedback from the US Food and Drug Administration, FDA, regarding the company’s planned pivotal clinical trial with ASTar in the United States.